MTOR and hepatocellular carcinoma: Collectively, these results revealed that long-term aberrant mTOR activation (in HCC patients) was associated with the dysregulation of DNA methylation spectrum, and short-term intervention in mTOR activities (in HCC cell lines) could also further modulate the DNA methylation profile, indicating that crosstalk between mTOR signalling and DNA methylation might exist.